Application Note: High throughput screening of cardiac ion channels
19 August 2020

Here Nanion Technologies GmbH, presents high-quality data with reliable pharmacology on hERG expressing CHO cells, NaV1.5, CaV1.2 or KvLQT1 expressed in HEK293 cells and Kir2.1 expressed in RBL cells on the SyncroPatch 384PE or Patchliner. Additionally, electrophysiological recordings on the Patchliner and Impedance measurements on the CardioExcyte 96 of stem cell-derived cardiomyocytes are shown.